Back to Search
ANGELA ENNO, PH.D.
PH.D.
Psychologist
NPI: 1386456044Individual
Specialties, Licenses & Credentials
Research & Publications (16)
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.
PMID 18464112·Leuk Lymphoma·2008
3-trial
Convergence and divergence among multiple methods for assessing adolescent romantic relationships.
PMID 18207231·J Adolesc·2008
8-other
Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.
PMID 17391493·Br J Haematol·2007
8-other
Genetic variations in benzene metabolism and susceptibility to multiple myeloma.
PMID 16949155·Leuk Res·2007
3-trial
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.
PMID 15213095·Blood·2005
3-trial
Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.
PMID 15136237·Haematologica·2004
4-observational
Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of 'Helicobacter heilmannii' infection.
PMID 15258991·J Pathol·2004
7-preclinical
Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation.
PMID 15258557·Bone Marrow Transplant·2004
8-other
Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients.
PMID 15167907·Hematol J·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 201 S 1460 E RM 426
SALT LAKE CITY, UT 84112 - Phone
- (801) 586-6826
Quick Facts
- NPI
- 1386456044
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile